TY - JOUR
T1 - Identification and characterization of a novel genetic mutation with prolonged QT syndrome in an unexplained postoperative death
AU - Hata, Yukiko
AU - Mori, Hisashi
AU - Tanaka, Ayumi
AU - Fujita, Yosuke
AU - Shimomura, Takeshi
AU - Tabata, Toshihide
AU - Kinoshita, Koshi
AU - Yamaguchi, Yoshiaki
AU - Ichida, Fukiko
AU - Kominato, Yoshihiko
AU - Ikeda, Noriaki
AU - Nishida, Naoki
N1 - Funding Information:
We thank Drs. Kenshi Hayashi (Kanazawa University Graduate School of Medical Science, Kanazawa, Japan), Sabina Kupershmidt (Vanderbilt University School of Medicine, Nashville, USA), and Jun-ichi Miyazaki (Osaka University Medical School, Osaka, Japan) for providing plasmids. We also thank Prof. K. Fukurotani for the opportunity to perform this work. This work was supported in part by KAKENHI grants from MEXT, Japan, to T.T. (19045019, 20022025, 20500284, 21026011, and 23500384) and a KAKENHI grant from JSPS, Japan, to Y.H. (24590852).
PY - 2014/1
Y1 - 2014/1
N2 - Introduction: The human ether-à-go-go-related gene (hERG) encodes the α-subunit of a cardiac potassium channel. Various mutations of hERG, including missense mutations, have been reported to cause long QT syndrome (LQTS) and severe arrhythmic disorders such as sudden cardiac death. We identified a novel hERG frameshift mutation (hERG(ΔAT)) in the S5-pore region from a LQTS patient who died suddenly and analyzed its genetic profile and the molecular and electrophysiological behaviors of the protein product to assess the pathogenicity of hERG(ΔAT). Methods and results: We performed direct sequencing of hERG and evaluated its transcript level by using a whole blood sample from the patient. We performed immunoblotting, immunocytochemistry, and patch-clamp recordings of HEK-293 T cells transfected with hERG(ΔAT), wild-type hERG (hERG(WT)), or both. The patient demonstrated an AT deletion (c.1735-1736del) in hERG and a decrease in hERG mRNA transcripts. HEK-293 T cells showed lower production and cell surface expression of hERG(ΔAT) compared with hERG(WT) protein. In addition, the hERG(â̂†AT) protein failed to form functional channels, while the activation kinetics of functional channels, presumably consisting of hERG(WT) subunits, were unaffected. Conclusion: The ΔAT mutation may decrease the number of functional hERG channels by impairing the posttranscriptional and posttranslational processing of the mutant product. This decrease may partly explain the cardiac symptoms of the patient who was heterozygous for hERG(ΔAT).
AB - Introduction: The human ether-à-go-go-related gene (hERG) encodes the α-subunit of a cardiac potassium channel. Various mutations of hERG, including missense mutations, have been reported to cause long QT syndrome (LQTS) and severe arrhythmic disorders such as sudden cardiac death. We identified a novel hERG frameshift mutation (hERG(ΔAT)) in the S5-pore region from a LQTS patient who died suddenly and analyzed its genetic profile and the molecular and electrophysiological behaviors of the protein product to assess the pathogenicity of hERG(ΔAT). Methods and results: We performed direct sequencing of hERG and evaluated its transcript level by using a whole blood sample from the patient. We performed immunoblotting, immunocytochemistry, and patch-clamp recordings of HEK-293 T cells transfected with hERG(ΔAT), wild-type hERG (hERG(WT)), or both. The patient demonstrated an AT deletion (c.1735-1736del) in hERG and a decrease in hERG mRNA transcripts. HEK-293 T cells showed lower production and cell surface expression of hERG(ΔAT) compared with hERG(WT) protein. In addition, the hERG(â̂†AT) protein failed to form functional channels, while the activation kinetics of functional channels, presumably consisting of hERG(WT) subunits, were unaffected. Conclusion: The ΔAT mutation may decrease the number of functional hERG channels by impairing the posttranscriptional and posttranslational processing of the mutant product. This decrease may partly explain the cardiac symptoms of the patient who was heterozygous for hERG(ΔAT).
KW - Arrhythmia
KW - Human ether-à-go-go-related gene
KW - Long QT syndrome
KW - M579fs + 75X frameshift mutation
KW - Patch-clamp
KW - Transmembrane pore domain
UR - http://www.scopus.com/inward/record.url?scp=84891765619&partnerID=8YFLogxK
U2 - 10.1007/s00414-013-0853-4
DO - 10.1007/s00414-013-0853-4
M3 - 学術論文
C2 - 23546179
AN - SCOPUS:84891765619
SN - 0937-9827
VL - 128
SP - 105
EP - 115
JO - International Journal of Legal Medicine
JF - International Journal of Legal Medicine
IS - 1
ER -